Pharmaceutical waste can create a serious hazard to human health and the environment if not disposed of safely. Proper disposal is even more important when the pharmaceutical waste is also classified as hazardous waste.
Compliance with the new EPA Pharmaceutical Rule, “Management Standards of Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” begins with a two-step process.
Continue reading “Sharps Compliance’s White Paper Explains the EPA’s New Hazardous Waste Pharmaceutical Rule – Is Your Facility Ready?”
The EPA’s recently finalized Pharmaceutical Rule is effective on August 21, 2019 – six months after being published in the Federal Register. This final rule, referred to as Subpart P, and titled “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine,” is a sector-based rule for the healthcare industry. Continue reading “EPA’s New Pharmaceutical Rule – Takes Effect 08/21/19”
The Environmental Protection Agency’s (EPA) long-awaited final rule for managing hazardous waste pharmaceuticals generated by healthcare facilities was finalized and published in the Federal Register on February 22, 2019. This rule had its origins in the EPA’s 2008 Universal Waste proposal for pharmaceutical waste – and perhaps even earlier based on comments to the EPA from retailers.
NIOSH vs RCRA
Are you confused by the terms “hazardous drug” and “hazardous waste pharmaceutical” (HWP)? Well, you are not alone. At first glance, it would appear they are the same, but they are not. Knowing the difference can save your facility money and potential regulatory citations. So, let’s clear the confusion.